Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122818
Filing Date
2024-11-07
Accepted
2024-11-07 08:00:21
Documents
54
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-20240930.htm   iXBRL 10-Q 2147397
2 EX-31.1 ikna-ex31_1.htm EX-31.1 16489
3 EX-31.2 ikna-ex31_2.htm EX-31.2 16576
4 EX-32.1 ikna-ex32_1.htm EX-32.1 14749
  Complete submission text file 0000950170-24-122818.txt   6673367

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ikna-20240930.xsd EX-101.SCH 852515
56 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20240930_htm.xml XML 911024
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 241433265
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)